Warfarin responses in total joint and hip fracture patients

Journal of Arthroplasty

Volumn 14, Issue 6, 1999, Pages 724-729

  Messieh, Michael ^a,c   Huang, Zhen ^b   Johnson, Linda J ^b   Jobin, Sherry ^a  

^a St Joseph's Hospital   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^c Aspen Medical Group   (United States)

Author keywords

Anticoagulation; International normalized ratio; Risk factors; Sensitivity; Warfarin

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSE CALCULATION; DRUG SAFETY; FEMALE; HIP FRACTURE; HUMAN; INCIDENCE; INTERNATIONAL STANDARD UNIT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OSTEOSYNTHESIS; RISK FACTOR; SENESCENCE; SEX DIFFERENCE; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

EID: 0032833841     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-5403(99)90228-0     Document Type: Article

References (14)

1. Shepherd A, Heswick D, Moreland T, et al: Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol 4:315, 1977
2. Gladman JRF, Dolan G: Effect of age upon the induction and maintenance of anticoagulation with warfarin. Postgrad Med J 71:153, 1995
3. Gurwitz JH, Avorn J, Ross-Degnan D, et al: Aging and the anticoagulant response to warfarin therapy. Ann Intern Med 16(11):901, 1992
4. Dobrzanski S, Duncan SE, Harkiss A, et al: Age and weight as determinants of warfarin requirements. J Clin Hosp Pharmacol 8:75, 1983
5. Kirking D, Cohen M, Shue M, Hutchison T: Relationship of age, weight and body surface area to warfarin maintenance dose requirements. J Clin Hosp Pharmacol 10:101, 1985
6. Hirsh J, Poller L: The international normalized ratio: a guide to understanding and correcting its problems. Arch Intern Med 154:282, 1994
7. Fihn SD, Mcdinell M, Martin D, et al: Risk factors for complications of chronic anticoagulation. Ann Intern Med 118:511, 1993
8. Isaacs C, Paltiel O, Blake G, et al: Age associated risks of prophylactic anticoagulation in the setting of hip fracture. Am J Med 96:487, 1994
9. Tan G, Cohen H, Taylor F, Gabby J: Audit of start of anticoagulation treatment in patients. J Clin Pathol 46:67, 1993
10. Harrison L, Johnston M, Massicotte MP, et al: Com parison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 126:133, 1997
11. Hirsh J, Dalen JE, Deykin D, Poller I: Oral anticoagulants mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 102:312, 1992
12. Buck ML: Anticoagulation with warfarin in infants and children. Ann Pharmacother 30:1316, 1996
13. Srephan DF, Callahan CM, Martin DC, et al: The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 124:970, 1996
14. Palareti G, Leali N, Coccheri S, et al: Bleeding complications of oral anticoagulant treatment. Lancet 348:423, 1996